BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

Samsung Biologics Reports First Quarter 2022 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced strong financial results for t...

April 28, 2022 | News

WuXi Biologics' 2021 ESG Report Reveals Company's Strong Commitment to Overall Sustainability

One example of WuXi Biologics' contribution to society is its rapid, robust pandemic response -- enabling nearly 30 Investigational New Drug Applications (...

April 28, 2022 | News

Samsung Biologics completes full acquisition of Samsung Bioepis

Samsung Biologics (KRX: 207940.KS) announced today that it has completed the purchase of Biogen's stake in the Samsung Bioepis joint venture for USD $...

April 21, 2022 | News

WuXi Biologics Receives Bioprocessing Excellence Award from IMAPAC

This marks the second consecutive year that WuXi Bio has received this award from IMAPAC, a leading consulting firm in biopharmaceutical industry. S...

April 18, 2022 | News

Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza

Merck to become first company to offer a fully integrated ecosystem for advanced process technologies Brings biopharmaceutical industry closer to digita...

April 14, 2022 | News

AGC to Expand Synthetic Pharmaceutical Production Base in Spain

A new building with a total floor area of 7,500 m2 will be constructed on the company's site, increasing the current production capacity by 30%. ...

April 11, 2022 | News

CDMO's Shifting Focus to Meet Future Demand

Transformational forces are influencing the global contract development and manufacturing organization (CDMO) market's growth. Disruptive, innovative busin...

April 08, 2022 | News

GenScript Receives "Best Contract Development and Manufacturing Organization Award" For the Third Time in a Row

This marks the third consecutive year of GenScript bagging the same award in Asia Pacific region. The award also follows GenScript's re...

March 31, 2022 | News

Rentschler Biopharma and Vetter Unveil Xpert Alliance

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced today that t...

March 29, 2022 | News

Samsung Biologics holds 11th Annual General Meeting of Shareholders

Five matters were presented and approved unanimously at this year's meeting, which included the approval of financial statement, appointment of directors, ...

March 29, 2022 | News

Genscript Biotech Reports 2021 Annual Results

Revenue of the Group for the year ended December 31, 2021 was approximately US$511.1 million, representing an increase of 30.8% as compare...

March 21, 2022 | News

I Peace triples GMP cell manufacturing by expanding CDMO facility

The facility's expansion, designed to conform to GMP standard, is now almost complete and is expected to start manufacturing cGMP grade cells in April this...

March 15, 2022 | News

Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model Development

CD34+ cell lots in a range of sizes also now available with high-resolution HLA information, eliminating the need for cumbersome and costly HLA screening...

March 08, 2022 | News

HCmed, Formosa Lab, and Formosa Pharma Signed MoU to Form a Global CDMO for Inhalation Treatment Drugs

By integrating HCmed's vibrating mesh nebulizers, Formosa Laboratories' drug development and manufacturing capabilities, and Formosa Pharmaceuticals' APNT ...

March 07, 2022 | News

Stay Connected